ABBV has been in the news 357% more than usual
Apr 30, 2025, 8:31 PM
-4.89%
What does ABBV do
AbbVie is a North Chicago-based biopharmaceutical company that develops and sells medicines across various therapeutic areas, employing 50,000 staff since its IPO in January 2013. Key products include Humira, Botox, and NX-13 for ulcerative colitis.
ABBV has been in the news recently: AbbVie’s RINVOQ (upadacitinib) is the first oral JAK inhibitor approved by the FDA for the treatment of giant cell arteritis in adults, demonstrating sustained remission in 46.4% of patients. AbbVie has also announced a $10 billion plan to enhance U.S. manufacturing in response to tariff threats.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.